HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis.

AbstractOBJECTIVE:
We investigated associations of HLA-B27 with clinical manifestations and longterm outcome in a near population-based setting among patients with juvenile idiopathic arthritis (JIA).
METHODS:
We studied clinical and serological data from 410 patients with HLA-B27 results among 440 prospectively collected patients with JIA with 8-year followup data in a Nordic database. The study was structured to be as close to a population-based study as possible.
RESULTS:
HLA-B27 was analyzed in 93% of patients, and was positive in 21% of the cohort, in 18.4% of the girls and in 25.9% of the boys. Boys who were HLA-B27-positive had significantly higher age at onset compared to HLA-B27-negative boys and compared to both HLA-B27-negative and positive girls. This difference in onset age in relation to HLA-B27 was not found in girls. HLA-B27 was associated with clinical signs of sacroiliitis, enthesitis, and tenosynovitis in boys, but not in girls. After 8 years of disease, 46 children (11.2%) were classified as having enthesitis-related arthritis (ERA). Boys with ERA had clinical signs of sacroiliitis more often than girls with ERA. HLA-B27-positive children, as well as children with clinical signs of sacroiliitis, enthesitis, and hip arthritis, had higher odds of not being in remission off medication after 8 years of disease.
CONCLUSION:
In this near population-based Nordic JIA cohort we found significant differences between HLA-B27-positive boys and girls in age at disease onset, clinical signs of sacroiliitis, and ERA classification. HLA-B27 was negatively associated with longterm remission status, possibly because of its association with clinical disease characteristics, such as sacroiliitis, rather than being a general marker of persistent disease.
AuthorsLillemor Berntson, Ellen Nordal, Kristiina Aalto, Suvi Peltoniemi, Troels Herlin, Marek Zak, Susan Nielsen, Marite Rygg, Nordic Study Group of Paediatric Rheumatology
JournalThe Journal of rheumatology (J Rheumatol) Vol. 40 Issue 5 Pg. 725-31 (May 2013) ISSN: 0315-162X [Print] Canada
PMID23547219 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-B27 Antigen
Topics
  • Age of Onset
  • Arthritis, Juvenile (blood, epidemiology, genetics, pathology)
  • Child
  • Child, Preschool
  • Female
  • Finland (epidemiology)
  • Genetic Predisposition to Disease
  • HLA-B27 Antigen (blood, genetics)
  • Humans
  • Joints (pathology)
  • Male
  • Prospective Studies
  • Scandinavian and Nordic Countries (epidemiology)
  • Severity of Illness Index
  • Sex Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: